Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Management of hallucinations and psychosis in Parkinson's disease.

Eng ML, Welty TE.

Am J Geriatr Pharmacother. 2010 Aug;8(4):316-30. doi: 10.1016/j.amjopharm.2010.08.004. Review.

PMID:
20869621
[PubMed - indexed for MEDLINE]
2.

Hallucinations and psychosis in Parkinson's disease.

Rabey JM.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S105-10. doi: 10.1016/S1353-8020(09)70846-6. Review.

PMID:
20123547
[PubMed - indexed for MEDLINE]
3.

Longitudinal outcome of Parkinson's disease patients with psychosis.

Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, Parsa M, Pfeiffer R; Parkinson Study Group.

Neurology. 2003 Jun 10;60(11):1756-61.

PMID:
12796526
[PubMed - indexed for MEDLINE]
4.

Treatment options for depression and psychosis in Parkinson's disease.

Poewe W, Seppi K.

J Neurol. 2001 Sep;248 Suppl 3:III12-21. Review.

PMID:
11697683
[PubMed - indexed for MEDLINE]
5.

Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease.

Voon V, Lang AE.

Clin Neuropharmacol. 2004 Mar-Apr;27(2):90-2.

PMID:
15252271
[PubMed - indexed for MEDLINE]
6.

Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.

Meco G, Bernardi S.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):311-3. Epub 2006 Aug 17.

PMID:
16919377
[PubMed - indexed for MEDLINE]
7.

Parkinson's disease psychosis 2010: a review article.

Friedman JH.

Parkinsonism Relat Disord. 2010 Nov;16(9):553-60. doi: 10.1016/j.parkreldis.2010.05.004. Epub 2010 Jun 9. Review.

PMID:
20538500
[PubMed - indexed for MEDLINE]
8.

Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.

Merims D, Balas M, Peretz C, Shabtai H, Giladi N.

Clin Neuropharmacol. 2006 Nov-Dec;29(6):331-7.

PMID:
17095896
[PubMed - indexed for MEDLINE]
9.

Clozapine and risperidone treatment of psychosis in Parkinson's disease.

Ellis T, Cudkowicz ME, Sexton PM, Growdon JH.

J Neuropsychiatry Clin Neurosci. 2000 Summer;12(3):364-9.

PMID:
10956570
[PubMed - indexed for MEDLINE]
10.

Threatening auditory hallucinations and Cotard syndrome in Parkinson disease.

Factor SA, Molho ES.

Clin Neuropharmacol. 2004 Sep-Oct;27(5):205-7.

PMID:
15602098
[PubMed - indexed for MEDLINE]
11.

Atypical antipsychotics in Parkinson-sensitive populations.

Friedman JH, Fernandez HH.

J Geriatr Psychiatry Neurol. 2002 Fall;15(3):156-70. Review.

PMID:
12230086
[PubMed - indexed for MEDLINE]
12.

Clozapine in Parkinson's disease psychosis: 5-year follow-up review.

Klein C, Gordon J, Pollak L, Rabey JM.

Clin Neuropharmacol. 2003 Jan-Feb;26(1):8-11.

PMID:
12567158
[PubMed - indexed for MEDLINE]
13.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
14.

Clozapine as a treatment for psychosis in Parkinson's disease: a review.

Musser WS, Akil M.

J Neuropsychiatry Clin Neurosci. 1996 Winter;8(1):1-9. Review.

PMID:
8845691
[PubMed - indexed for MEDLINE]
15.

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.

Int J Geriatr Psychiatry. 2007 May;22(5):475-84.

PMID:
17471598
[PubMed - indexed for MEDLINE]
16.

Pharmacologic management of psychosis in dementia.

Schneider LS.

J Clin Psychiatry. 1999;60 Suppl 8:54-60. Review.

PMID:
10335671
[PubMed - indexed for MEDLINE]
17.

[Psychosis in Parkinson's disease].

Rongve A, Auning E, Ehrt U, Arsland D.

Tidsskr Nor Laegeforen. 2012 Jan 24;132(2):155-8. doi: 10.4045/tidsskr.11.0723. Review. Norwegian.

PMID:
22278271
[PubMed - indexed for MEDLINE]
Free Article
18.

[Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].

Kashihara K, Ohno M, Katsu Y.

Rinsho Shinkeigaku. 2005 Jan;45(1):1-5. Japanese.

PMID:
15714992
[PubMed - indexed for MEDLINE]
19.

Performance of the scale for assessment of positive symptoms in Parkinson's disease psychosis.

Voss TS, Brocht AF, Ravina B.

Mov Disord. 2010 Jan 15;25(1):124-5. doi: 10.1002/mds.22575. No abstract available.

PMID:
19412941
[PubMed - indexed for MEDLINE]
20.

Scales to assess psychosis in Parkinson's disease: Critique and recommendations.

Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG.

Mov Disord. 2008 Mar 15;23(4):484-500. doi: 10.1002/mds.21875.

PMID:
18175343
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk